Pharmacokinetics of 5-fluorouracil after intravenous infusion of 5-fluorouracil-acetic acid-human serum albumin conjugates to rabbits
暂无分享,去创建一个
So H. Kim | Myung G. Lee | K. Chong-Kook | S. Chung | M. Park | E. Yoon | Lee Heejoo
[1] Chong-K. Kim,et al. Pharmacokinetics of methotrexate after intravenous infusion of methotrexate-rabbit serum albumin conjugate to rabbits , 1991 .
[2] A. Florence,et al. Characterization of in‐vitro drug release and biological activity of methotrexate‐bovine serum albumin conjugates , 1987, The Journal of pharmacy and pharmacology.
[3] M. Nahabedian,et al. Pharmacokinetics of 5-fluorouracil in rabbits in experimental regional chemotherapy. , 1986, Cancer research.
[4] W. L. Chiou,et al. Pharmacokinetics in blood IV: unusual distribution, storage effect and metabolism of methotrexate. , 1984, International journal of clinical pharmacology, therapy, and toxicology.
[5] F. Balis,et al. Clinical Pharmacokinetics of Commonly Used Anticancer Drugs , 1983, Clinical pharmacokinetics.
[6] W. L. Chiou,et al. Arterial and venous blood sampling in pharmacokinetic studies: griseofulvin. , 1982, Journal of pharmaceutical sciences.
[7] M. Hashida,et al. Physico-chemical and antitumor characteristics of high molecular weight prodrugs of mitomycin C. , 1982, Chemical & pharmaceutical bulletin.
[8] M. Masquelier,et al. A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Howell,et al. Differential toxicity of carrier-bound methotrexate toward human lymphocytes, marrow and tumor cells. , 1981, Biochemical pharmacology.
[10] W. L. Chiou,et al. Pharmacokinetics of drugs in blood. I. Unusual distribution of gentamicin. , 1981, Biopharmaceutics & drug disposition.
[11] W. L. Chiou. New calculation method for mean apparent drug volume of distribution and application to rational dosage regimens. , 1979, Journal of pharmaceutical sciences.
[12] B. Chu,et al. High molecular weight derivatives of methotrexate as chemotherapeutic agents. , 1977, Molecular pharmacology.
[13] W J Jusko,et al. Plasma and tissue protein binding of drugs in pharmacokinetics. , 1976, Drug metabolism reviews.
[14] M. Tada. Antineoplastic Agents. The Preparation of 5-Fluorouracil-1-acetic Acid Derivatives , 1975 .
[15] G. Chheda,et al. Nonclassical Antimetabolites XVIII: Simulation of 5′-Phosphoribosyl Binding II. ω-Uracil Alkanoic Acids Related to 2′-Deoxyuridylate , 1965 .
[16] H. Ryser. THE MEASUREMENT OF I131-SERUM ALBUMIN UPTAKE BY TUMOR CELLS IN TISSUE CULTURE. , 1963, Laboratory investigation; a journal of technical methods and pathology.
[17] H. Busch,et al. Studies on the metabolism of radioactive albumin in tumor-bearing rats. , 1961, Cancer research.